Tempus AI
Publicly traded precision-medicine company combining genomic/molecular diagnostics with an AI data platform for oncology and other specialties; raised 2026 revenue guidance to ~$1.6B.
This is where the depth lives — everything below is evidence-graded
How the product is positioned
Publicly traded precision-medicine company combining genomic/molecular diagnostics with an AI data platform for oncology and other specialties; raised 2026 revenue guidance to ~$1.6B.
Our summary of the vendor’s positioning — verbatim claim not yet recordedWhat we found
Level 1 · assistive
Seeded at the rubric default. No independent evidence of end-to-end task completion has been reviewed yet, so the lowest grade applies until it is.
Any human checkpoint here is a product setting, not a regulatory requirement — confirm how it is configured for your deployment.
Graded 2026-08-01 · re-check 2026-11-01
Procurement detail
- Deployment
- saasvendor documentation
- Compliance
- HIPAA · CLIA-certified labsreport dates not disclosed — request before signing
- Integrations
- Major EHRs claim unverifiedoncology lab workflows claim unverified
- Pricing
- usageDiagnostics billed per test/panel; data/applications licensed to pharma partners; not fully public.
- Human checkpoint
- Requiredproduct setting
- Named customers
- Major cancer centers and pharma partners (not individually named in sources)from cited sources
Will they still be here?
- Funding
- NASDAQ: TEM; Q1 2026 revenue $348.1M (+36.1% YoY); FY2026 guidance ~$1.59-$1.60B; acquired Paige (digital pathology)
- Founded
- 2015
- HQ
- Chicago, USA
- Ownership
- NASDAQ: TEM; Q1 2026 revenue $348.1M (+36.1% YoY); FY2026 guidance ~$1.59-$1.60B; acquired Paige (digital pathology)
Sources
- investors.tempus.comVendor-published · retrieved 2026-08-01
- mlq.aiIndependent · retrieved 2026-08-01
Where it’s weak
Still transitioning to sustained profitability; stock trades on growth expectations that require continued high revenue growth.
Corrections
Vendors may submit factual corrections free of charge. We correct facts and publish the change. We do not accept payment to change a grade. Submit a correction →